Purolite Corporation today announced that it has engaged Evercore Group L.L.C. to assist the Company in growing its Healthcare and Life Sciences Segment. Purolite is exploring strategic acquisitions to accelerate the growth of its business. This announcement follows Purolite’s recent announcement that it is expanding its manufacturing capabilities to address and fulfill the increasing global demand for its healthcare and life science products.
“Purolite was extremely well positioned to weather the COVID-related downturn in 2020 and experienced unprecedented growth in both its core ion exchange business and life sciences business,” said Steve Brodie, Purolite President and CEO. “Purolite is already a world-class international manufacturing business. While we have historically grown our business organically, we are now at a size where it makes sense to consider strategic acquisitions in related life science and healthcare segments to accelerate our growth into the next decade. We are excited to work with Evercore as we evaluate these strategic opportunities,” added Mr. Brodie.
Source: Biospace
